AGPT registrars can commence applying to practices for the 2025.2 placement round through the Training Management System (TMS) from Monday, 28 April. Due to this, we are anticipating higher-than-usual traffic to our TMS. Although this may result in slower load times, we will actively be monitoring TMS performance and making necessary changes to remediate any issues. We apologise for any inconvenience this may cause and appreciate your patience and understanding.
Standards for point-of-care testing
Introduction
In Australia, PoCT devices and systems are categorised as in-vitro diagnostic medical devices (IVDs) and are therefore regulated as a subset of medical devices by the Therapeutic Goods Administration.
The Australian Register of Therapeutic Goods (ARTG) lists therapeutic goods that can be legally imported into Australia, or supplied for use in Australia, or exported from Australia.
Unless a specific exemption has been granted, it is a criminal offence under the Therapeutic Goods Act 1989 to import into, supply in or export from Australia a medical device that is not listed on the ARTG.
The Standards for PoCT assume that your practice’s PoCT devices or systems, including but not limited to consumables, reagents, controls and software, are listed on the ARTG.
Advertising